Medtronic's cranial and spine technologies division saw a slight revenue decrease in the second quarter of the 2022 fiscal year, and the company earned $7.84 billion in total revenue.
Spinal Tech
Johnson & Johnson on Nov. 12 announced its plan to split into two separate companies — one focusing on medical devices and drugs, and the other focusing on consumer health products.
DePuy Synthes, the orthopedic arm of Johnson & Johnson, launched the Unium System for trauma and small bone procedures, according to a Nov. 22 news release.
The spine fusion device market is expected to reach almost $9 billion in the next six years, according to Emergen Research.
The FDA's Breakthrough Devices Program is designed to accelerate the development, assessment and review of medical devices that provide effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions.
Patient-specific implants, which tout more accurate spine and orthopedic surgery, have made several advances in 2021. Reception among surgeons remains mixed, however.
OsteoCentric Technologies acquired the Integrity Sacroiliac Fusion System.
Artificial disc replacement technology has made significant strides in 2021. Here's a breakdown of three artificial discs making headlines.
From Medtronic's new spine leader to Johnson & Johnson's planned split, here are eight key updates from spine and orthopedic device companies in the last week:
Aurora Spine reached a sales milestone in the third quarter, according to financial results posted Nov. 16.
